gyki 52466 has been researched along with Anochlesia in 6 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "The process of catalepsy sensitization incorporates different learning stages." | 1.37 | The role of NMDA and AMPA/Kainate receptors in the consolidation of catalepsy sensitization. ( Kulak, A; Riedinger, K; Schmidt, WJ; von Ameln-Mayerhofer, A, 2011) |
| "This type of 'catalepsy' is clearly different from the state which is produced by the administration of neuroleptics, e." | 1.29 | Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist. ( Schmidt, WJ; Tzschentke, TM, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riedinger, K | 1 |
| Kulak, A | 1 |
| Schmidt, WJ | 4 |
| von Ameln-Mayerhofer, A | 1 |
| Zadow, B | 1 |
| Hauber, W | 2 |
| Waldenmeier, MT | 1 |
| Andersen, R | 1 |
| Tzschentke, TM | 1 |
| Kretschmer, BD | 1 |
| Kratzer, U | 1 |
6 other studies available for gyki 52466 and Anochlesia
| Article | Year |
|---|---|
The role of NMDA and AMPA/Kainate receptors in the consolidation of catalepsy sensitization.
Topics: Analysis of Variance; Animals; Benzodiazepines; Catalepsy; Dizocilpine Maleate; Dopamine Antagonists | 2011 |
The AMPA antagonists NBQX and GYKI 52466 do not counteract neuroleptic-induced catalepsy.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catalepsy; Dizocilpine Maleate; | 1994 |
The AMPA receptor antagonist GYKI 52466 reverses the anti-cataleptic effects of the competitive NMDA receptor antagonist CGP 37849.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Catalep | 1994 |
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Catalepsy; Dizocilpine Maleate; Excitatory Amino Acid | 1993 |
Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anti-Anxiety Agents; Benzodiazepines; Catalepsy; Dizocilpine M | 1996 |
Riluzole, a glutamate release inhibitor, and motor behavior.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Behavior, Animal; Benzazepines; Benzodiazepines; | 1998 |